Alkermes
ALKS
#3169
Rank
โ‚น426.20 B
Marketcap
โ‚น2,581
Share price
-2.30%
Change (1 day)
-1.68%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): โ‚น35.08 Billion

According to Alkermes's latest financial reports the company's current earnings are โ‚น1.52 Billion. In 2024 the company made an earning of โ‚น42.23 Billion a decrease over its 2023 earnings that were of โ‚น51.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น35.08 B-16.92%
2024 โ‚น42.23 B-17.97%
2023 โ‚น51.48 B-468.52%
2022 -โ‚น13.98 Billion449.24%
2021 -โ‚น2.55 Billion-68.04%
2020 -โ‚น7.96 Billion-52.1%
2019 -โ‚น16.62 Billion64.49%
2018 -โ‚น10.11 Billion-15.04%
2017 -โ‚น11.89 Billion-34.2%
2016 -โ‚น18.07 Billion-5.34%
2015 -โ‚น19.09 Billion35084.97%
2014 -โ‚น54.26 Million
2012 โ‚น0.67 B-117.81%
2011 -โ‚น3.78 Billion-12.69%
2010 -โ‚น4.33 Billion94.3%
2009 -โ‚น2.23 Billion-117.7%
2008 โ‚น12.57 B622.63%
2007 โ‚น1.73 B
2004 -โ‚น6.89 Billion-14.48%
2003 -โ‚น8.05 Billion11.88%
2002 -โ‚น7.2 Billion39.65%
2001 -โ‚น5.15 Billion5.73%
2000 -โ‚น4.88 Billion-28.91%
1999 -โ‚น6.86 Billion237.28%
1998 -โ‚น2.04 Billion100.05%
1997 -โ‚น1.02 Billion-37.93%
1996 -โ‚น1.64 Billion82.72%
1995 -โ‚น0.9 Billion-26.79%
1994 -โ‚น1.23 Billion-72.78%
1993 -โ‚น4.5 Billion208.07%
1992 -โ‚น1.46 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Acorda Therapeutics
ACOR
-โ‚น24.62 Billion-167.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น727.54 B 1,880.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.934 T 7,886.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.073 T 2,822.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.185 T 3,127.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น160.49 B 336.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
-โ‚น19.21 Billion-152.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น824.21 B 2,143.60%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
โ‚น1.487 T 3,947.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland